论文已发表
注册即可获取德孚的最新动态
IF 收录期刊
Authors Chen Y, Zhang F, Zhao Y, He K, Zheng X, Pan Y, Shao D, Shang P, Yang Y, Zhang D, Xie Y, Yao X, Chen L, Li J, Zhang X
Received 18 January 2018
Accepted for publication 3 May 2018
Published 1 June 2018 Volume 2018:11 Pages 3281—3292
DOI https://doi.org/10.2147/OTT.S162978
Checked for plagiarism Yes
Review by Single-blind
Peer reviewers approved by Dr Andrew Yee
Peer reviewer comments 2
Editor who approved publication: Dr Jianmin Xu
Background: Obesity was a recognized risk factor for the development and
progression of hepatocellular carcinoma (HCC). However, the effects and
mechanisms by which obesity promotes HCC metastasis remain poorly understood.
Materials and
methods: We cultured adipocyte induced by
preadipocyte 3T3-L1 in vitro and established HCC metastasis model in obesity
mouse in vivo to mimic the tumor microenvironment in obese status. The
mechanisms underlying obesity-associated miR-27a upregulation promoting HCC
metastasis were investigated.
Results: In this study, we showed that miR-27a was upregulated in
adipocytes, obese mouse model and clinical samples, and the increased miR-27a
level promoted migration and invasion in HCC cells, increased the number of
metastasis nodes in obese mouse model, and was associated with poor clinical
outcomes. Overexpressed secreted frizzled-related protein 1 in HCC cells and
tissues significantly alleviated the upregulation of β-catenin and matrix
metalloproteinase-7 induced by high level of miR-27a. Meanwhile, the E-cadherin
expression decreased and Vimentin expression increased, linking with high level
of β-catenin in high-fat group.
Conclusion: Taken together, our results have elucidated the critical role of
extracellular miR-27a as a pro-metastatic factor in HCC and revealed that
obesity-associated miR-27a upregulation promoted HCC metastasis through
activated Wnt/β-catenin signaling by suppressing secreted frizzled-related
protein 1. Our findings shed light on the novel mechanism underlying HCC
metastasis and provided miR-27a as a promising target for obese liver cancer
therapy.
Keywords: obesity, miR-27a, SFRP1, β-catenin, hepatocellular carcinoma